AGX vs TECH · P/E 31, rev $874.2M vs P/E 65, rev $1.22B
Argan Inc (AGX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Argan Inc (AGX) is a engineering & construction company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AGX revenue for 2025-01-31 was $874.2M. Net income was $85.5M. Revenue was up 52.5% from 2024-01-31 to 2025-01-31. AGX currently screens at market cap $3.00B and trailing P/E 30.7.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AGX currently screens at market cap $3.00B and trailing P/E 30.7. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AGX and TECH stock pages for the full models.
Not investment advice.